Drug Information

Drug General Information
Drug ID
D07SKJ
Former ID
DIB013856
Drug Name
LY3015014
Drug Type
Antibody
Indication Cardiovascular disorder [ICD10:I00-I99] Phase 2 [524347]
Company
Eli lilly
Target and Pathway
Target(s) Proprotein convertase subtilisin/kexin type 9 Target Info [532996]
WikiPathways PCSK9-mediated LDLR degradation
References
Ref 524347ClinicalTrials.gov (NCT01890967) A Study of LY3015014 in Participants With High Cholesterol. U.S. National Institutes of Health.
Ref 532996The dyslipidaemia market. Nat Rev Drug Discov. 2014 Nov;13(11):807-8.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.